HF
CNTB

HRT Financial’s Connect Biopharma Holdings CNTB Stock Holding History

HRT Financial’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40K Sell
15,299
-1,486
-9% -$3.87K ﹤0.01% 3479
2025
Q4 		$47K Buy
16,785
+6,328
+61% +$13.5K ﹤0.01% 2879
2025
Q3 		$15K Buy
+10,457
New +$18.5K ﹤0.01% 2728

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

HRT Financial's CNTB Position: Q1 2026 in Review

HRT Financial reduced its Connect Biopharma Holdings (CNTB) stake by 8.9% in Q1 2026, selling an estimated $3.87K and leaving 15,299 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #3479.

HRT Financial first reported a position in CNTB in Q3 2025 and has held it in 3 quarters since. The position peaked at $47K in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • HRT Financial held 15,299 shares of Connect Biopharma Holdings worth $40K as of Q1 2026.
  • HRT Financial sold 1,486 Connect Biopharma Holdings shares in Q1 2026, an estimated $3.87K.
  • Connect Biopharma Holdings made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3479 holding.
  • HRT Financial first reported a position in Connect Biopharma Holdings in Q3 2025 and has held it in 3 quarters since.
  • HRT Financial's Connect Biopharma Holdings position peaked at $47K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.